Invention Grant
US08153649B2 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes
失效
具有用于治疗1型和2型糖尿病的SGLT1和SGLT2抑制作用的3-氨基咪唑1,2-A吡啶衍生物
- Patent Title: 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes
- Patent Title (中): 具有用于治疗1型和2型糖尿病的SGLT1和SGLT2抑制作用的3-氨基咪唑1,2-A吡啶衍生物
-
Application No.: US12445661Application Date: 2007-09-27
-
Publication No.: US08153649B2Publication Date: 2012-04-10
- Inventor: Markus Klein , Rolf Gericke , Norbert Beier , Bertram Cezanne , Christos Tsaklakidis , Werner Mederski
- Applicant: Markus Klein , Rolf Gericke , Norbert Beier , Bertram Cezanne , Christos Tsaklakidis , Werner Mederski
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
- Current Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102006048728 20061016
- International Application: PCT/EP2007/008424 WO 20070927
- International Announcement: WO2008/046497 WO 20080424
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D513/02
Abstract:
Novel compounds of the formula (I), in which W, T, R1, R2, R3, R4, R5 and R6 have the meanings indicated in Patent Claim (1), are suitable as antidiabetics.
Public/Granted literature
Information query
